Pulmonary infections with Pneumocystis carinfi are an important cause of morbidity and mortality in patients with AIDS. P. carinii infections are seen in patients with decreased numbers of helper T lymphocytes, suggesting that these cells are important in preventing infection. To test this hypothesis, we sought to establish experimental infection with P. carinfi in mice selectively depleted of helper T lymphocytes. Weekly injections of a monoclonal anti-CD4 antibody produced sustained depletion of helper T lymphocytes from blood and lymphoid organs. To establish pulmonary infection, lymphocytedepleted mice were then given intratracheal inoculations of P. carinji organisms derived from the lungs of chronically infected athymic mice. Pulmonary infection with P. carinli was demonstrable in the antibody-treated mice and was centered around the conducting airways. Infection was persistent for up to 3 mo with continued antibody treatments, and yet could be cleared from the lungs if antibody treatments were discontinued. This experimental model of P. carinji infection permits
fection has been heavily dependent on animal models. However, existing animal models preclude definitive study of host defenses against P. carinii because they require either animals with congenital immunosuppression (8, 9) or corticosteroid treatment (10) , which has multiple effects on the immune system. Because decreased numbers of helper T lymphocytes are typically seen in AIDS (1 1), this study was undertaken to determine whether P. carinii pneumonia could be established experimentally in mice depleted of helper T lymphocytes.
Surface expression of the CD4 molecule correlates with helper-inducer function in lymphocytes (12) . Weekly injection of mice with an anti-CD4 monoclonal antibody depletes circulating blood and lymphoid tissues of helper T lymphocytes (13, 14) . Selective depletion of CD4-positive cells has been used previously to examine host defense mechanisms against Leishmania major (15) , Giardia muris (16) , Trypanosoma cruzi (17) , andHistoplasma capsulatum (18) . In the experiments reported here, we depleted normal BALB/c mice of CD4-positive lymphocytes by weekly injection with anti-CD4 monoclonal antibody and then instilled P. carinii organisms into the lungs by intratracheal inoculation. Our goals were to establish infection in mice that was reproducible, persistent, and associated with a discrete and potentially reversible immune defect. The results indicate that P. carinii pneumonia can be reproducibly established in such lymphocyte-depleted mice, and that the pulmonary infection is persistent if anti-CD4 treatment is maintained but reversible if antibody treatment is discontinued.
Methods
Animals. Virus-free, male BALB/c mice were purchased at 4-5 wk of age from Bantin & Kingman, Inc. (Fremont, CA). Male athymic (nul nu) mice with chronic P. carinii infection were purchased from Charles River Breeding Laboratories, Inc. (K95 colony; Kingston, NY). All mice were housed in the Animal Care Facility ofthe Veterans Administration (VA) Medical Center, San Francisco, in filtered cages and laminar flow hoods. The mice were provided with sterile mouse chow and sterile water ad lib. This research was approved by the Animal Studies Committee at the VA Medical Center, San Francisco.
Anti-CD4 monoclonal antibody. The hybridoma GKl.5, which produces a rat IgG2b monoclonal antibody against CD4 (12), was obtained from the American Type Culture Collection (Rockville, MD) and harvested as ascites from uninfected athymic (nu/nu) mice. The antibody was partially purified by ammonium sulfate precipitation, dialyzed against PBS, and quantified by protein electrophoresis and measurement of optical density (14, 19) . To deplete mice of helper T lymphocytes, mice received weekly intraperitoneal injections of0.1 mg anti-CD4 antibody in 0.2 ml PBS. This dose ofanti-CD4 antibody was chosen to target peripheral blood and lymphoid organs but not the thymus (Ermak, T. H., unpublished results). Higher doses of anti-CD4 modulate surface CD4 on thymocytes and alter differentiation pathways for T lymphocytes within the thymus (20) (21) (22) , whereas lower doses stimulate production of antibodies against the administered antibody (23).
Preparation of P. carinii inoculum. P. carinii-infected athymic mice were killed by a lethal dose of intraperitoneal pentobarbital (400 mg/kg) and exsanguinated by severing the abdominal aorta. Lungs were removed and touch preparations stained with Diff-Quik (AHS del Caribe, Inc., Aguada, PR) were examined for bacterial and fungal organisms. Lungs free of bacteria or fungi were selected for the inoculum and frozen at -20'C for 2 h. After freezing, the lungs from 4-10 athymic mice were pooled into PBS and homogenized in a tissue stomacher (model 80; Tekmar Co., Cincinnati, OH). This homogenate was then passed through a layer of surgical gauze and centrifuged at 500 g for 10 min at 50C. The pellet was then resuspended in PBS (0.5 ml PBS for each mouse lung added), and this suspension was used as the intratracheal inoculum. Microscopic counts ofP. carinii cyst forms were performed on 5-,41 smears of the inoculum stained with DiffQuik, and the concentration was adjusted to at least 2 x 105-2 X 10' cysts/ml PBS. To insure viability of the injected P. carinii organisms, the inoculum was injected into recipient mice on the same day it was prepared.
Intratracheal inoculation ofP. carinii. To inoculate recipient mice, a modification of a technique described for intratracheal injection of organic antigen was used (24) . Recipient mice were anesthetized with intraperitoneal pentobarbital (80 mg/kg) and placed supine with the head elevated 45 degrees. A midline incision in the neck was made to expose the trachea. An 18-gauge blunt needle was then passed through the mouth into the trachea, and its position was verified visually. A polyethylene catheter (PE 10; Clay Adams, Parsippany, NJ) was threaded through the needle so that the catheter tip extended just beyond the needle in the mid-trachea. The inoculum (0.1 ml) was then injected through the catheter into the lungs of the recipient mice, immediately followed by 0.25 ml of air. The anti-CD4-treated mice were removed and dissociated mechanically into RPMI 1640 medium containing 100 U/ml penicillin, 100 upg/ml streptomycin, 10 mM Hepes, and 2 mM glutamine (all from Gibco Laboratories, Grand Island, NY). The medium was also supplemented with 5% fetal bovine serum (J. R. Scientific, Woodland, CA). Whole blood was removed by cardiac puncture and purified by Ficoll-Hypaque centrifugation (25) . Red 
Results
Depletion of CD41 cells with anti-CD4 antibody. Flow cytometric analysis of spleen and blood cells from P. carinii-infected mice administered 2, 6, or 10 weekly injections of anti-CD4 antibody showed depletion of CD4-positive T lymphocytes in comparison to uninfected control mice injected with PBS or rat IgG (Fig. 1) . When calculated as a percentage of total lymphocytes, spleen cells from mice given 10 weekly injections of anti-CD4 antibody contained 0% CD4' cells (Table  I ). The percentages of lymphocytes that expressed the CD8 marker or neither CD4 or CD8 were also not altered by anti-CD4 treatment (Table 1) . Treatment with anti-CD4 antibody alone did not result in signs of clinical illness or weight loss in comparison to normal mice.
Although the anti-CD4 antibody targeted and depleted CD4-positive cells in the spleen and peripheral blood, little antibody was found on the surface ofcells in the thymus using an antibody to rat kappa chain (data not shown). Furthermore, there was virtually no change in the proportion of thymocyte subsets detected by staining with anti-CD4 and anti-CD8 (CD4+/CD8' thymocytes: 67±3% treated vs. 64±2% control; CD4+/CD8-thymocytes: 18±1 vs. 16±1%). An analysis ofthe levels of CD4 on thymocyte subpopulations indicated that most CD4 sites on CD4' thymocytes had not been targeted or modulated in their expression (data not shown).
Frequency ofinfection in treated and control mice. In mice treated with anti-CD4 antibody and then given two intratracheal inoculations of P. carinii, infection with P. carinii was visible on methenamine-silver-stained sections of lung tissue from 1 to 12 wk after the second intratracheal inoculation. The results of an experimental protocol analyzing mice 8-12 wk after intratracheal inoculation with P. carinii organisms are°0 P. carinii-infected mice were able to clear pulmonary infection when treatment with anti-CD4 antibody was stopped. This was demonstrated in a group of mice inoculated with P. carinii organisms, in which the anti-CD4 antibody treatments were discontinued 2 wk after the second inoculation. When these mice were killed at 8, 10, and 12 wk, the percentage of mice infected was lower than in a concurrent group of mice with continued anti-CD4 treatment (Fig. 2) . The percentage of mice with demonstrable infection showed a steady decline in the group without anti-CD4 treatment, such that no infection was present in these mice 12 wk after the second intratracheal inoculation. In comparison, 60% of animals with continued anti-CD4 antibody treatments were infected at 12 wk.
Histopathology of P. carinii infection. Lung tissue from mice killed 3 d after the second intratracheal injection of P. carinii showed essentially normal histology by hematoxylineosin stain (Fig.3 A) and only rare intra-alveolar cysts by methenamine-silver stain (not shown). By 7 d after the second intratracheal injection, lung tissue clearly showed increased numbers of P. carinii organisms. In animals with focal infection, involved alveoli were present adjacent to the conducting airways, while moderate and extensive infection included progressively more alveoli (Fig. 3 B) . Involved alveoli contained abundant alveolar macrophages, often with vacuolated cytoplasm, as well as the characteristic eosinophilic exudate (Fig. 3   B) . In addition, a periarteriolar lymphocytic infiltrate was consistently present, usually in close proximity to alveoli containing P. carinii. Methenamine-silver-stained sections showed clusters of P. carinii cysts easily visible within the alveolar spaces of infected mice (Fig. 3 C) . Trophozoite forms of P. carinii were also visible in touch preparations of lung tissue stained with Diff-Quik (not shown).
When methenamine-silver-stained slides of lung tissue from the P. carinii-infected mice were graded for intensity of infection, a stable and persistent infection was evident up to 12 wk after the second intratracheal inoculation of P. carinii organisms (Fig. 4) . Lymphocyte-depleted mice killed 3 d after intratracheal inoculation showed only rare intra-alveolar cysts. Control mice given intratracheal inoculations but no anti-CD4 antibody also showed no residual P. carinii organisms by 2 wk after the second inoculation. Therefore, P. carinii present in mice depleted of CD4-positive lymphocytes did not represent residual organisms from the inoculum, but probably represented organisms proliferating in situ.
Discussion
The results of these experiments demonstrate that pulmonary infection with P. carinii can be reproducibly established in the lungs of mice depleted of helper T lymphocytes by treatment with anti-CD4 antibody. In comparison to other animal models of P. carinii infection, this model may provide new information about the pathogenesis of P. carinii infection.
Because this new model of P. carinii infection allows precise control over the time course of experimental infection, involves a well-characterized immune defect, and permits the study of clearance of infection, it has advantages in comparison to existing experimental models. P. carinii infection does not occur in immunocompetent animals, and all experimental models of infection require some form of immunosuppression. Corticosteroid-treated rats have been used extensively as an experimental model of P. carinii infection (34) after both reactivation oflatent infection and intratracheal inoculation of P. carinii organisms (35) . Unfortunately, recent changes in commercial breeding techniques have made it difficult to establish infection in rats treated with corticosteroids (36, 37) , and the multiple biologic effects of corticosteroids (38) confound the study of specific host responses or treatment of P. carinii infection. Congenitally athymic mice also develop lowintensity P. carinii infection with advanced age (8) and have been used as a model ofP. carinii pneumonia, but this form of immunodeficiency cannot be reversed to study clearance of infection. In addition, alterations in the host defense mechanisms of athymic mice extend beyond the recognized deficit in circulating T lymphocytes to include exaggerated macrophage and natural killer cell function as well (39) .
Normal host defenses against P. carinii infection have not been clarified, but it is likely that a defect in cell-mediated immunity is necessary for infection to occur (40) . Cell-mediated immunity is critically dependent on lymphocytes bearing the glycoprotein CD4 (12) . In mice, CD4 is present on the surface of helper/inducer T lymphocytes but not macrophages (41) . Treatment of mice with anti-CD4 antibody has been shown previously to produce profound but selective depletion of helper T lymphocytes in blood, lymph node, and spleen (13, 14, 19) . The dose of anti-CD4 antibody used in this study depleted CD4-positive T cells in spleen and peripheral blood but did not significantly affect the T cell precursor population in the thymus. Our ability to induce P. carinii infection in such mice depleted of CD4-bearing cells suggests that helper T lymphocytes are important in host defense against this pathogen. The reported induction of P. carinii infection in rats treated with cyclosporine also supports this idea (42) .
Although our experiments implicate helper T lymphocytes in host defense against P. carinii infection, helper T lymphocytes may not be the only form of host defense against P. carinii. It is possible that the perivascular infiltrates observed in our P. carinii-infected mice reflect recruitment into the lungs of effector lymphocytes other than CD4-bearing cells. Alveolar macrophages (43) , polymorphonuclear leukocytes (44) , and alveolar epithelial cells (45) (46) (47) may also be involved in the pathogenesis of infection. The selective immunosuppression used in the model described here will allow investigators for the first time to study the role of these cells as well as helper T lymphocytes in host defense against P. carinii infection.
These experiments also delineate possible modes of spread of P. carinii within the lung. In mice with focal alveolitis, in which small numbers of alveoli were involved with infection, the involved alveoli were consistently adjacent to terminal bronchioles. As 
